Recursion Pharmaceuticals is reshaping drug discovery with AI, strategic partnerships, and financial discipline for long-term ...

The candidates merge two existing vaccines that have demonstrated favourable tolerability through randomised controlled ...

Johnson & Johnson and other pharma companies aim to change how the 340B Drug Pricing Program functions. Courts must rule if ...

Dupilumab treatment improves signs and symptoms of atopic dermatitis (AD) in young children, according to a study published ...

Innovations in rare blood disorders took center stage at the 2024 American Society of Hematology (ASH) Annual Meeting & ...

The US Food and Drug Administration(FDA) has granted Fast Track designation to two non-mRNA combination vaccine candidates ...

Sanofi SNY announced that the FDA has granted a Fast Track designation to two combination vaccine candidates to prevent ...

HighTower Advisors LLC boosted its position in Sanofi (NASDAQ:SNY – Free Report) by 1.0% during the 3rd quarter, according to ...

Why digital measurements startup Koneksa Health thinks it can help pharma measure if their drugs are effective in people with ...

Published in Nature Communications, a new study led by the University of Minnesota Medical School and Duke University found that a DNA sequencing test for advanced prostate cancer patients can ...

Sanofi CEO Paul Hudson says, "AI is a huge opportunity, and we can't be deniers." ...